Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1249743.RA_5L3hXvMf1vRhmWsFXL8D1881EPQe6g-t2LxCTePwPk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1249743.RA_5L3hXvMf1vRhmWsFXL8D1881EPQe6g-t2LxCTePwPk130_assertion type Assertion NP1249743.RA_5L3hXvMf1vRhmWsFXL8D1881EPQe6g-t2LxCTePwPk130_head.
- NP1249743.RA_5L3hXvMf1vRhmWsFXL8D1881EPQe6g-t2LxCTePwPk130_assertion description "[Furthermore, by taking account of genomic mutations causing transcriptional aberrations, we could improve the sensitivity of deleterious mutation detection in known cancer driver genes (TP53, AXIN1, ARID2, RPS6KA3), and identified recurrent disruptions in putative cancer driver genes such as HNF4A, CPS1, TSC1 and THRAP3 in HCCs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1249743.RA_5L3hXvMf1vRhmWsFXL8D1881EPQe6g-t2LxCTePwPk130_provenance.
- NP1249743.RA_5L3hXvMf1vRhmWsFXL8D1881EPQe6g-t2LxCTePwPk130_assertion evidence source_evidence_literature NP1249743.RA_5L3hXvMf1vRhmWsFXL8D1881EPQe6g-t2LxCTePwPk130_provenance.
- NP1249743.RA_5L3hXvMf1vRhmWsFXL8D1881EPQe6g-t2LxCTePwPk130_assertion SIO_000772 25526364 NP1249743.RA_5L3hXvMf1vRhmWsFXL8D1881EPQe6g-t2LxCTePwPk130_provenance.
- NP1249743.RA_5L3hXvMf1vRhmWsFXL8D1881EPQe6g-t2LxCTePwPk130_assertion wasDerivedFrom befree-2016 NP1249743.RA_5L3hXvMf1vRhmWsFXL8D1881EPQe6g-t2LxCTePwPk130_provenance.
- NP1249743.RA_5L3hXvMf1vRhmWsFXL8D1881EPQe6g-t2LxCTePwPk130_assertion wasGeneratedBy ECO_0000203 NP1249743.RA_5L3hXvMf1vRhmWsFXL8D1881EPQe6g-t2LxCTePwPk130_provenance.